This episode features Sandra Visser and Anne Chain from Merck & Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs. You can read Dr. Visser's Review "Implementation of Quantitative and Systems Pharmacology in Large Pharma" by clicking here.

Listen and subscribe for free on iTunes and Google Play